Strand AI
Multimodal foundation models to predict uncollected patient biology
O firmie
Opis firmy po angielsku
Strand AI develops foundation models to generate missing bio-data about patients. With this imputed data, pharmaceutical companies can select better patients for their drug trials and shave months from their drug launch timelines. We’ve already trained a multimodal foundation model that integrates spatial biology modalities, beating SOTA at a fraction of the cost.
Tematy
HealthcareDrug Discovery and Delivery
- Lokalizacja
- San Francisco, CA, USA
- Wielkość zespołu
- Pracownicy: 2
- Edycja YC
- Winter 2026
- Status
- Aktywny
- Etap
- Wczesny etap
